
TREVIA MET 50 500MG TAB 28s
Trevia Met 50/500mg Tablet 28s – Sitagliptin & Metformin for Type 2 Diabetes
Trevia Met Tablet combines Sitagliptin 50mg and Metformin 500mg, two effective antidiabetic agents used to control high blood sugar levels in patients with type 2 diabetes mellitus. Sitagliptin works by increasing incretin levels, which help regulate insulin release and decrease glucose production in the liver, while Metformin improves insulin sensitivity and reduces glucose absorption in the intestines. This dual-action formula helps achieve better glycemic control and reduces the risk of diabetes-related complications.
Uses:
-
Management of type 2 diabetes mellitus
-
Helps maintain healthy blood sugar levels
-
Can be used alone or in combination with other diabetes medications
Benefits:
-
Dual-action control with Sitagliptin & Metformin
-
Improves insulin response and sensitivity
-
Reduces fasting and post-meal blood glucose levels
-
Supports long-term diabetes management
-
May help prevent diabetes-related complications like kidney damage, nerve problems, and heart disease
Possible Side Effects:
-
Nausea, vomiting, or diarrhea
-
Stomach upset or abdominal pain
-
Headache or dizziness
-
Low blood sugar (hypoglycemia) when used with other antidiabetic drugs
-
Rarely, lactic acidosis (seek immediate medical help if symptoms like rapid breathing, muscle pain, or unusual fatigue occur)
Note: Use only as prescribed by your healthcare provider and monitor blood sugar regularly.
